Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation

Braeuning, Albert; Kollotzek, Ferdinand; Zeller, Eva; Knorpp, Thomas; Templin, Markus F.; Schwarz, Michael

dc.contributor.author	Kollotzek, Ferdinand
dc.contributor.author	Zeller, Eva
dc.contributor.author	Schwarz, Michael
dc.contributor.author	Braeuning, Albert
dc.date.accessioned	2019-07-10T06:53:11Z
dc.date.available	2019-07-10T06:53:11Z
dc.date.issued	2018
dc.identifier.issn	1521-009X
dc.identifier.uri	http://hdl.handle.net/10900/90207
dc.language.iso	en	de_DE
dc.publisher	Amer Soc Pharmacology Experimental Therapeutics	de_DE
dc.relation.uri	http://dx.doi.org/10.1124/dmd.118.083014	de_DE
dc.subject.ddc	610	de_DE
dc.title	Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00514
utue.publikation.seiten	1462-1465	de_DE
utue.personen.roh	Braeuning, Albert
utue.personen.roh	Kollotzek, Ferdinand
utue.personen.roh	Zeller, Eva
utue.personen.roh	Knorpp, Thomas
utue.personen.roh	Templin, Markus F.
utue.personen.roh	Schwarz, Michael
dcterms.isPartOf.ZSTitelID	Drug Metabolism and Disposition	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	46	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE